BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180409
DTEND;VALUE=DATE:20180411
DTSTAMP:20260515T064535
CREATED:20171106T103751Z
LAST-MODIFIED:20171107T020509Z
UID:3819-1523232000-1523404799@www.pharmajournalist.com
SUMMARY:Digital Pharma Japan
DESCRIPTION:The inaugural Digital Pharma Japan conference will deliver a world class event for Japanese pharmaceutical and medical device executives to learn how to embed a digital ecosystem that is tailored for execution specifically in the Japanese business model. \n  \nTo learn more about this event\, and to register online\, visit http://digitalpharmaseries.com/japan
URL:https://www.pharmajournalist.com/event/digital-pharma-japan/
LOCATION:The Westin Tokyo\, 1-4-1 Mita Meguro-ku\, Tokyo\, Tokyo 153-8580\, Japan
ORGANIZER;CN="ExL Events":MAILTO:digitalpharma@exlevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180409
DTEND;VALUE=DATE:20180411
DTSTAMP:20260515T064535
CREATED:20171109T010959Z
LAST-MODIFIED:20171109T011019Z
UID:3890-1523232000-1523404799@www.pharmajournalist.com
SUMMARY:10th annual Adaptive Designs in Clinical Trials
DESCRIPTION:Now running for 10 years\, SMi’s annual conference on Adaptive Designs in Clinical Trials will return to London on 9th and 10th April 2018. \n \nThis year’s agenda has been curated to provide you with the latest innovations\, regulatory updates\, and strategies on how industry and clinical experts are currently using adaptive designs in their clinical trials for successful drug\, medical device and therapy development. \nGiving you a fresh take on this vital area of biopharma\, the event will ride the wave of technology within the pharmaceutical industry\, as we consider how the increasing use of smartphone apps and digital devices is changing the way trials run. Simultaneously\, the event will also explore how adaptive designs are being used for the production of personalised medicines and personalised therapies. \n  \nFeatured Speakers include: \n– James Matcham\, Head of Biometrics\, Early Clinical Development\, AstraZeneca\n– Alex Sverdlov\, Director\, Statistical Scientist\, Novartis\n– Frank Fleisher\, Principal Methodology Statistician\, Boehringer-Ingelheim\n– Christine Fletcher\, Executive Director Biostatistics\, Amgen\n– Chris Harbron\, Principal Statistical Scientist\, Roche\n– Olivier Collignon\, Biostatistician\, European Medicines Agency\n– Beatrice Panico\, Medical Advisor\, MHRA\n– Corine Baayen\, Senior Biostatistician\, H.Lundbeck \nKey Highlights \n– Explore the current industry outlook and evaluate the promises and challenges of digital technology use\n– Hear exciting case studies on enrichment designs and group sequential trials\n– Discover how big pharma companies are using Platform Trials and self-adapting priors to advance their adaptive clinical trials\n– Examine the use of adaptive clinical trials are used to produce targeted therapies\n– Learn from the latest regulatory perspectives from MHRA and EMA\, including planning and assessing umbrella and basket trials \nEarly Bird: Book by Dec 15 to save £400. Book by Jan 31 to save £200. Book by 28 Feb to save £100. \nTo learn more about this event\, and to register online\, visit http://www.adaptivedesigns.co.uk/pharmajournalist
URL:https://www.pharmajournalist.com/event/10th-annual-adaptive-designs-clinical-trials/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:hdegracia@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180409
DTEND;VALUE=DATE:20180411
DTSTAMP:20260515T064535
CREATED:20180115T131419Z
LAST-MODIFIED:20180115T131741Z
UID:7654-1523232000-1523404799@www.pharmajournalist.com
SUMMARY:Antibodies & Antibody Drug Conjugates
DESCRIPTION:SMi is proud to present their 6th annual Antibodies and Antibody Drug Conjugates conference\, being held at the Copthorne Tara Hotel\, London\, UK on the 9th – 10th April 2018.With an every-growing industry\, the market is expected to reach USD 30 Billion by 2023.www.adcsummit.com/pjl \nAntibodies and antibody drug conjugates (ADCs) have the potential to make a ground-breaking impact upon medicinal therapies\, diagnostics and characterization of diseases. There is massive potential for ADCs to be used in the development of targeted solid tumour therapies\, due to their ability to act as precisely and effectively on target antigens. \nJoin us this April 2018\, as SMi’s ADC Summit conference brings together industry experts from leading life science and pharmaceutical companies. Key topics that will be covered in the upcoming event include: fragment drug conjugates\, ADC payloads\, site-selective ADCs/ site-specific conjugation and the best linker and warhead combinations. \nHow Will You Benefit? \nNetwork and learn from leading professionals such as: \nChairs for 2018: \n– MahendraDeonarain\, Chief Executive and Scientific Officer\, Antikor Biopharma\n– Rakesh Dixit\, Vice President and Global Head Biologics Safety Assessment\, Medimmune \nKey Speakers Include: \n– Robert Lyon\, Senior Director\, Seattle Genetics\n– Arnaud Tiberghien\, Scientist II\, Spirogen\n– Alison Betts\, Associate Research Fellow\, Pfizer\n– Thomas Pillow\, Senior Scientist\, Genentech\n– Andreas Pahl\, CSO\, Heidelberg Pharma\n– Carlo Boutton\, Director of Technology\, Ablynx \nSome Featured Highlights will include: \n– Learn about the implementation of superior technologies to develop more effective and efficient Antibody Drug Conjugates.\n– Discover new and novel payloads\, e.g. Antibody Targeted Amanitin Conjugates (ATACs) and minorgroove binding DNA-interactive molecules as ADC payloads\, to expand the ADC landscape.\n– Discuss the practicalities of the use of Highly Potent Active Pharmaceutical Ingredients.\n– Refine the practice of using fragment conjugates in order to develop a tailored therapy for solid tumours.\n– Design principles for maximising the drug delivery efficiency and therapeutic index. \nView the full agenda: www.adcsummit.com/pjl
URL:https://www.pharmajournalist.com/event/antibodies-antibody-drug-conjugates/
LOCATION:Copthorne Tara Hotel\, London\, UK
ORGANIZER;CN="SMi Group Ltd":MAILTO:psolanki@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180415
DTSTAMP:20260515T064535
CREATED:20171025T014409Z
LAST-MODIFIED:20180111T031457Z
UID:3596-1523404800-1523750399@www.pharmajournalist.com
SUMMARY:The Health Industry Summit(tHIS)
DESCRIPTION:The Health Industry Summit(tHIS) – EXPO and Congress is the umbrella global Pharmaceutical and Medical industry event in Asia\, the world’s fastest growing health market. It brings together CMEF\, PharmChina and API China in one place at the same time\,the only event providing complete coverage of the health industry.It enables leading academics and professionals from around the world to meet and share the latest innovation and thinking on policies & investment\, R&D\, Manufacturing & distribution\,education & hospital applications and related services for the industry. \n\nTo learn more about this event\, and to register online\, visit https://goo.gl/5qrDQX \n 
URL:https://www.pharmajournalist.com/event/health-industry-summit-this-2018/
LOCATION:National Exhibition and Convention Center (Shanghai)
ORGANIZER;CN="Reed Sinopharm Exhibitions":MAILTO:james.wang@reedsinopharm.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180413
DTSTAMP:20260515T064535
CREATED:20171128T075734Z
LAST-MODIFIED:20171128T075957Z
UID:4686-1523404800-1523577599@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes East Coast
DESCRIPTION:Enabling the next generation of Pre-Filled Syringes from design to manufacturing \nBuilding on the success of previous sell-out shows\, SMi Group is delighted to announce the return of the 5th annual conference and exhibition: Pre-Filled Syringes – East Coast\, taking place on April 11th – 12th 2018 in Boston\, Massachusetts\, USA. \n \nA rise in chronic diseases\, improvements in technology and a growing demand for easy to use drug administration products has in recent years\, created a booming Pre-Filled Syringes industry. \nSome notable areas of increased attention have been the broader trends for combination products and biologics\, as well as the move towards digital health and improving patient adherence due to increased self-administration figures. As well as these areas of lucrative opportunity\, there are still several ongoing challenges that the key-thought leaders are battling to overcome such as chemical compatibility\, user safety\, high-volume and highly viscous formulation\, and non-compliance. \nPre-Filled Syringes East Coast will once again play host to an international audience of drug delivery\, medical device and PFS experts to discuss emerging trends and offer innovative solutions to the challenges facing the prefilled industry\, helping attendees to secure global success for their PFS device. \nFeatured Speakers Include: \n– Dhairyamehta\, Associate Director of Device and Combination Products\, Shire\n– Stephen Barat\, Head of Pre-Clinical and Early Clinical Development\, Scynexis\n– Susan Neadle\, Head\, Combination Products Center of Excellence\, Sr. Director\, Quality Engineering & Design-to-Value\, Janssen Pharmaceuticals\n– Justin Wright\, Vice President\, Drug Delivery Innovation\, DDR&D Technology\, Eli Lilly\n– TiemingRuan\, Associate Director of Device Development\, Takeda\n– Molly Story\, Head\, Global Usability Engineering and Risk Management\, Sanofi\n– Gary Henniger\, R&D Director\, Discovery and Product Development R&D\, Teva\n– Michael Song\, Pharmaceutical Device and Digital Health\, Medimmune\n– Steve Bowman\, Device Program Lead\, Shire\n– Gary Mills\, Associate Director\, Drug Product Development\n– Kashappa Goud Desai\, Investigator\, Biopharmaceutical Product Sciences\, GlaxoSmithKline\n– Maria Linzmayer\, Associate Director\, Drug Delivery Devices\, Merck \nReasons to Attend: \n– Navigate through the regulatory landscape through guidance on compliance\n– Understand end-use interaction with delivery systems and Human Factor engineering\n– Receive insight on delivering high concentration formulations.\n– Integrate Quality-by-Design (QbD) principles for best practice solutions in developing your combination products.\n– Updates on new technologies\, including digital monitoring biomarkers from Eli Lilly; electronic enabled drug delivery devices from MedImmune; and PFS tech transfer of in-line products from Merck.\n– Hear the latest results from recent studies in chemical compatibility; comparison of COP vs glass; and container integrity.\n– Participate in our two interactive panel discussions and gain from over 5 hours of dedicated networking time. \nA snapshot of confirmed sponsors includes: Mitsubishi Gas Chemical\, Nemera\, NN\, Inc Precision Engineered Products\, SCHOTT\, Schreiner MediPharm\, Terumo Pharmaceutical Solutions\, Zeon \nFor more information or register\, visit http://www.pfsamericas.com/pjournalist \nTo get in touch\, contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-east-coast-2018/
LOCATION:Sheraton Boston Hotel\, 39 Dalton Street\, Boston\, MA\, 02199\, United States
ORGANIZER;CN="SMi Group Ltd":MAILTO:tarri@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180411
DTEND;VALUE=DATE:20180413
DTSTAMP:20260515T064535
CREATED:20180131T133231Z
LAST-MODIFIED:20180201T152133Z
UID:8955-1523404800-1523577599@www.pharmajournalist.com
SUMMARY:Asthma & COPD
DESCRIPTION:SMi is excited to announce the latest event in their Asthma & COPD series\, which returns to London on the 11th-12th April 2018. \nWith asthma and chronic obstructive pulmonary disorder (COPD) affecting about 500 million people worldwide\, opportunities in drug development are vast and reducing serious attacks by improving adherence could save $19 billion a year in U.S. healthcare costs* http://reut.rs/2xqyBjZ \nRecent advances in injectable biologics and smart medical devices as led to an increase in novel approaches to treating severe asthma and COPD as well as the regulations to take into consideration. As technology soars\, the need for guideline updates from regulators has increased and continues to be modified. \nJoin us as we discuss current clinical trials and the innovative digital technology being used to improve clinical adherence. Leading industry experts will be looking at the use of ‘real world data’ human factors in the design of medical devices and triple combination treatments on the market. We will also be looking at asthma and COPD Phenotyping and biomarker application and differences between in the EU and US for the approval of biologics. We will be exploring the complexities of dry powder formulation and helping you determine clinical efficacy and endpoints. \nTo learn more about this event\, and to register online\, visit www.asthma-copd.co.uk/pharmajourno
URL:https://www.pharmajournalist.com/event/asthma-copd/
LOCATION:Copthorne Tara Hotel\, London
ORGANIZER;CN="SMi Group Ltd":MAILTO:acaddick@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180423
DTEND;VALUE=DATE:20180426
DTSTAMP:20260515T064535
CREATED:20180212T145329Z
LAST-MODIFIED:20180212T145839Z
UID:9857-1524441600-1524700799@www.pharmajournalist.com
SUMMARY:BioProcess International European Summit
DESCRIPTION:Bringing together 900+ attendees from all major departments in bioprocessing: Cell Culture\, Downstream\, Manufacturing\, Vaccines\, Viral Safety and Cell Line Development this April in Amsterdam\, BPI Europe 2018 will provide you with the latest advice on how optimise bioprocessing through connecting science\, technology and business. \n\n\nEurope’s largest bioprocessing event – 275+ Companies from the Biopharmaceutical Industry\n7 events 1 location –  BPI Europe 2018 offers in depth programmes across all phases of bioprocessing\n80% NEW Speakers – Including senior-level bioprocessing professionals from Amgen\, Biogen\, Takeda\, Bayer\, Boehringer Ingelhiem\, Pall LifeSciences and other top companies\nMore than just presentations – BPI Live Labs and BPI Innovation Lab demonstrate a series of practical products – Evaluate latest technologies and troubleshooting\nAll of the plenary speakers are EXCLUSIVE to BPI Europe – Unavailable at any other meetings\nRising Stars Platform – Showcasing the upcoming talent in bioprocessing today\nNew partnering platform: partneringONE\n\nAnd much more \nTo learn more about this event\, and to register online\, visit http://bit.ly/2BVwpmL
URL:https://www.pharmajournalist.com/event/bioprocess-international-european-summit/
LOCATION:RAI Congress\, Amsterdam
ORGANIZER;CN="Knect365 Life Science":MAILTO:LS.Registrations@Knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180424
DTEND;VALUE=DATE:20180426
DTSTAMP:20260515T064535
CREATED:20180108T083612Z
LAST-MODIFIED:20180108T083612Z
UID:6935-1524528000-1524700799@www.pharmajournalist.com
SUMMARY:Clinical Operations in Oncology Trials West Coast 2018
DESCRIPTION:Rising above local competition through optimisation of operationally efficient\, targeted oncology trials which engage West Coast physicians and patients \nThis unique event brings together leading pharma and biotech professionals working in the oncology space from across the West Coast region. After a hugely successful 2017 event\, the Clinical Operations in Oncology Trials West Coast Conference will be returning to Burlingame for its 5th edition\, with more content and senior level speakers than before. \nOur 2018 programme is jam packed with interactive sessions and case studies\, allowing you to gain practical take-aways in this highly competitive region. \nAcross the two day event we will explore innovative strategies in patient recruitment and retention\, vendor management and patient centricity\, for better efficiency and trial outcomes. You will hear from the likes of Genentech\, Amgen\, Astex Pharmaceuticals\, Pharmacyclics\, Forty Seven and many more. \nCTO West will be returning on April 24th & 25th 2018 to Burlingame. Please get in touch if you are interested in taking part! \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/oncologywestcoast/
URL:https://www.pharmajournalist.com/event/clinical-operations-oncology-trials-west-coast-2018/
LOCATION:TBC
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180424
DTEND;VALUE=DATE:20180426
DTSTAMP:20260515T064535
CREATED:20180125T101005Z
LAST-MODIFIED:20180125T101005Z
UID:8466-1524528000-1524700799@www.pharmajournalist.com
SUMMARY:Temperature Controlled Logistics in Biopharmaceuticals USA 2018
DESCRIPTION:After an extremely successful first edition\, Temperature Controlled Logistics in Biopharmaceuticals is back in Princeton in April 2018! Our presenter will proved you with highly informative content about shipping products which must be kept at given temperatures\, clinical and commercial operations overviews and real life case studies. You will enjoy meeting industry leaders to gain insights into new trends for the biopharmaceutical industry and hear opinions and strategies for incorporation into existing processes at your organization. You will have the chance to potentially find solutions to your packaging technology\, too! All of the aspects of the supply chain will be covered\, not only cold chain – this way we will have an incredibly holistic view on each step of your work! The conference is going to be so interactive – you will have the chance to ask questions to senior executives working in so many different departments – Quality\, Compliance\, Logistics and Packaging. \nTo learn more about this event\, and to register online\, visit http://www.arena-international.com/pharmatempusa/
URL:https://www.pharmajournalist.com/event/temperature-controlled-logistics-biopharmaceuticals-usa-2018/
LOCATION:Princeton\, New Jersey
ORGANIZER;CN="Arena International":MAILTO:brijesh.patel@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180424
DTEND;VALUE=DATE:20180427
DTSTAMP:20260515T064535
CREATED:20180212T083552Z
LAST-MODIFIED:20180212T083716Z
UID:9832-1524528000-1524787199@www.pharmajournalist.com
SUMMARY:eRegulatory Summit
DESCRIPTION:eRegulatory Summit | 24-26 April | SANA Lisboa Hotel\, Lisbon \n\nWith changes across the regulatory landscape including SPOR\, Brexit\, and the evolving TMF model\, the 2018 eRegulatory Summit includes three jam packed days with the experts to create an industry led conference\, which includes tracks on Global eCTD Management\, Regulatory Information Management & IDMP Compliance\, Trial Master File and a Filing Variations workshop day. Check out our website and agenda with 60+ industry speakers and 8+ competent Authorities from around the world. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2H9IkfY
URL:https://www.pharmajournalist.com/event/eregulatory-summit/
LOCATION:SANA Lisboa Hotel\, Lisbon
ORGANIZER;CN="KNect365 Life Sciences":MAILTO:LS.Registrations@Knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180425
DTEND;VALUE=DATE:20180427
DTSTAMP:20260515T064535
CREATED:20171214T080333Z
LAST-MODIFIED:20171214T080356Z
UID:5346-1524614400-1524787199@www.pharmajournalist.com
SUMMARY:Global Clinical Trials Connect 2018
DESCRIPTION:The Global Clinical Trials Connect 2018 conference focuses on introducing pioneer technology\, developing better patient engagement and collaborating strategies in clinical trials. With the right commitment and attention to detail\, contract research organizations (CROs) and pharmaceutical companies can drive collaboration with greater efficiency. \nThis conference will bring together the industry experts and leaders across pharmaceutical\, biotechnological and CRO’s for brainstorming on Case studies on innovation\, collaboration and existing clinical data to headway the Clinical Trials process. Ethical considerations are given in this context and for this RBM are beginning to extend its concepts in Quality Risk Management; clinical trial predictive models are accumulated by enterprises\, methodologies in trial design and many more. \nTo learn more about this event\, and to register online\, visit http://bit.ly/2AXX4Mv
URL:https://www.pharmajournalist.com/event/global-clinical-trials-connect-2018/
LOCATION:Holiday Inn London Kensington (TBC)
ORGANIZER;CN="Corvus Global Events Limited":MAILTO:info@corvusglobalevents.com
END:VEVENT
END:VCALENDAR